153 related articles for article (PubMed ID: 17804730)
1. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
Bromberg KD; Kluger HM; Delaunay A; Abbas S; DiVito KA; Krajewski S; Ronai Z
Cancer Res; 2007 Sep; 67(17):8172-9. PubMed ID: 17804730
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
Jeon YJ; Khelifa S; Ratnikov B; Scott DA; Feng Y; Parisi F; Ruller C; Lau E; Kim H; Brill LM; Jiang T; Rimm DL; Cardiff RD; Mills GB; Smith JW; Osterman AL; Kluger Y; Ronai ZA
Cancer Cell; 2015 Mar; 27(3):354-69. PubMed ID: 25759021
[TBL] [Abstract][Full Text] [Related]
3. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
5. RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization.
Didier C; Broday L; Bhoumik A; Israeli S; Takahashi S; Nakayama K; Thomas SM; Turner CE; Henderson S; Sabe H; Ronai Z
Mol Cell Biol; 2003 Aug; 23(15):5331-45. PubMed ID: 12861019
[TBL] [Abstract][Full Text] [Related]
6.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers.
Li X; Wang F; Huang L; Yang M; Kuang E
Cell Death Dis; 2023 Oct; 14(10):662. PubMed ID: 37816703
[TBL] [Abstract][Full Text] [Related]
8. Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability.
Roy SJ; Glazkova I; Fréchette L; Iorio-Morin C; Binda C; Pétrin D; Trieu P; Robitaille M; Angers S; Hébert TE; Parent JL
Mol Endocrinol; 2013 Aug; 27(8):1245-66. PubMed ID: 23798571
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.
Yang LL; Xiao WC; Li H; Hao ZY; Liu GZ; Zhang DH; Wu LM; Wang Z; Zhang YQ; Huang Z; Zhang YZ
Cell Death Dis; 2022 Oct; 13(10):889. PubMed ID: 36270989
[TBL] [Abstract][Full Text] [Related]
10. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
[TBL] [Abstract][Full Text] [Related]
11. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
12. Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.
Tang W; Li Y; Yu D; Thomas-Tikhonenko A; Spiegelman VS; Fuchs SY
Cancer Res; 2005 Mar; 65(5):1904-8. PubMed ID: 15753389
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination.
Ding MJ; Fang HR; Zhang JK; Shi JH; Yu X; Wen PH; Wang ZH; Cao SL; Zhang Y; Shi XY; Zhang HP; He YT; Yan B; Tang HW; Guo DF; Gao J; Liu Z; Zhang L; Zhang SJ; Zhang XJ; Guo WZ
Hepatology; 2022 Jul; 76(1):94-111. PubMed ID: 34735734
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
Khateb A; Deshpande A; Feng Y; Finlay D; Lee JS; Lazar I; Fabre B; Li Y; Fujita Y; Zhang T; Yin J; Pass I; Livneh I; Jeremias I; Burian C; Mason JR; Almog R; Horesh N; Ofran Y; Brown K; Vuori K; Jackson M; Ruppin E; Deshpande AJ; Ronai ZA
Nat Commun; 2021 Sep; 12(1):5397. PubMed ID: 34518534
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors.
Principi E; Sondo E; Bianchi G; Ravera S; Morini M; Tomati V; Pastorino C; Zara F; Bruno C; Eva A; Pedemonte N; Raffaghello L
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406574
[TBL] [Abstract][Full Text] [Related]
16. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
[TBL] [Abstract][Full Text] [Related]
17. The amplified WWP1 gene is a potential molecular target in breast cancer.
Chen C; Zhou Z; Ross JS; Zhou W; Dong JT
Int J Cancer; 2007 Jul; 121(1):80-87. PubMed ID: 17330240
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA.
Zhong B; Zhang L; Lei C; Li Y; Mao AP; Yang Y; Wang YY; Zhang XL; Shu HB
Immunity; 2009 Mar; 30(3):397-407. PubMed ID: 19285439
[TBL] [Abstract][Full Text] [Related]
19. +TIP EB1 downregulates paclitaxel‑induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules.
Thomas GE; Sreeja JS; Gireesh KK; Gupta H; Manna TK
Int J Oncol; 2015 Jan; 46(1):133-46. PubMed ID: 25310526
[TBL] [Abstract][Full Text] [Related]
20. A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase.
Ruan J; Liang D; Yan W; Zhong Y; Talley DC; Rai G; Tao D; LeClair CA; Simeonov A; Zhang Y; Chen F; Quinney NL; Boyles SE; Cholon DM; Gentzsch M; Henderson MJ; Xue F; Fang S
Mol Biol Cell; 2022 Nov; 33(13):ar120. PubMed ID: 36074076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
